polyarticular


Also found in: Dictionary, Wikipedia.

polyarticular

 [pol″e-ahr-tik´u-lar]
affecting many joints; polyarthric.

mul·ti·ar·tic·u·lar

(mŭl'tē-ar-tik'yū-lăr),
Relating to or involving many joints.
[multi- + L. articulus, joint]

polyarticular

/poly·ar·tic·u·lar/ (-ahr-tik´u-lar) affecting many joints.

polyarticular

[-ärtik′yələr]
Etymology: Gk, polys, many, articulus, joint
pertaining to many joints.

mul·ti·ar·tic·u·lar

(mŭl'tē-ahr-tik'yū-lăr)
Relating to or involving many joints.
Synonym(s): polyarthric, polyarticular.
[multi- + L. articulus, joint]

polyarticular

affecting many joints; polyarthric.
References in periodicals archive ?
10) It is polyarticular in approximately two-thirds of patients, and often occurs in an asymmetric pattern.
The report provides comprehensive information on the therapeutics under development for Polyarticular Juvenile Idiopathic Arthritis (PJIA), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
The disease has four stages: asymptomatic hyperuricemia, acute gouty arthritis, polyarticular gouty arthritis (Chronic, long-standing disease] and chronic tophaceous gout (soft tissue accumulation of sodium monourate].
The cuboid is the only bony structure supporting the lateral column of the midfoot [1], and it is required to maintain polyarticular alignment of the tarsal bones (the calcaneus, the lateral cuneiform, and the fourth and fifth metatarsals) [2].
While it shows polyarticular symmetric involvement in adults, the pattern in children has been reported to be asymmetric distal involvement.
Objective: To see the radiographic cervical spine damage in polyarticular juvenile idiopathic arthritis (PJIA) coming to a tertiary care hospital in Islamabad, Pakistan.
Conclusion: Polyarticular arthritis was the most common sub-type.
It was approved for use in polyarticular JIA in children by the Food and Drug Administration (FDA) in 1999.
ABP 501 is being developed as a biosimilar to adalimumab, an anti-TNF-monoclonal antibody approved for the treatment of inflammatory diseases, including rheumatoid arthritis, plaque psoriasis (PsO), polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease and ulcerative colitis.
For example, right now, CADTH is reviewing drugs to manage chronic obstructive pulmonary disease, heart failure, ulcerative colitis, schizophrenia, vitreomacular adhesion, chronic migraine, Parkinson disease, growth hormone deficiency in adults and children, Turner Syndrome, and polyarticular juvenile idiopathic arthritis.
Very rare cases in the wrist, elbow, shoulder, hip, and ankle have been reported, as well as an even smaller number of bilateral and polyarticular cases (4).